2014
DOI: 10.4103/0974-7168.129680
|View full text |Cite
|
Sign up to set email alerts
|

Proceedings of interactive meet on harmonisation of drug proving programme

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 1 publication
0
2
0
Order By: Relevance
“…11 The publication should be based on the drug proving/homeopathic pathogenetic trials reporting guidelines. 12 & Clinical trials involving humans Indian Council of Medical Research (ICMR) ethical guidelines suggest that a trial should be initiated and continued only if the expected benefits are expected to outweigh the risks. Before testing on humans, each drug should be tested in vitro and in vivo (animal studies) to determine the efficacy, toxicity, pharmacokinetic and safety information.…”
Section: Evolution Of Ethics In Medical Researchmentioning
confidence: 99%
See 1 more Smart Citation
“…11 The publication should be based on the drug proving/homeopathic pathogenetic trials reporting guidelines. 12 & Clinical trials involving humans Indian Council of Medical Research (ICMR) ethical guidelines suggest that a trial should be initiated and continued only if the expected benefits are expected to outweigh the risks. Before testing on humans, each drug should be tested in vitro and in vivo (animal studies) to determine the efficacy, toxicity, pharmacokinetic and safety information.…”
Section: Evolution Of Ethics In Medical Researchmentioning
confidence: 99%
“…11 The publication should be based on the drug proving/homeopathic pathogenetic trials reporting guidelines. 12…”
Section: Introductionmentioning
confidence: 99%